Showing 201 - 220 results of 16,594 for search '(( 50 mg decrease ) OR ( 50 ((((meann decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.49s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205

    Pyridoxine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…Riboflavin 50mg with microcrystalline cellulose, pyridoxine hydrochloride 50mg with microcrystalline cellulose and biotin 40 mg with microcrystalline cellulose/silica are stable for one year when stored at 25 <sup>°</sup>C/ 60% RH protected from light. …”
  6. 206

    Thiamine chlorhydrate forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…Riboflavin 50mg with microcrystalline cellulose, pyridoxine hydrochloride 50mg with microcrystalline cellulose and biotin 40 mg with microcrystalline cellulose/silica are stable for one year when stored at 25 <sup>°</sup>C/ 60% RH protected from light. …”
  7. 207

    Riboflavine forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…Riboflavin 50mg with microcrystalline cellulose, pyridoxine hydrochloride 50mg with microcrystalline cellulose and biotin 40 mg with microcrystalline cellulose/silica are stable for one year when stored at 25 <sup>°</sup>C/ 60% RH protected from light. …”
  8. 208

    Biotin forced degradation. by Marine Bonino (21156835)

    Published 2025
    “…Riboflavin 50mg with microcrystalline cellulose, pyridoxine hydrochloride 50mg with microcrystalline cellulose and biotin 40 mg with microcrystalline cellulose/silica are stable for one year when stored at 25 <sup>°</sup>C/ 60% RH protected from light. …”
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213

    DataSheet_1_Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients.docx by Zijing Ran (11429935)

    Published 2021
    “…Subjects included had all been treated with urate-lowering therapy (ULT) (febuxostat 20–80 mg/day or benzbromarone 25–50 mg/day, validated by the medical record). …”
  14. 214
  15. 215

    Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy by Maude Giroud (2017114)

    Published 2025
    “…When tested in vivo, compound <b>7</b> showed efficacy after oral dosing in a mouse model of peripheral nerve injury by decreasing plasma neurofilament light (NfL) levels at 50 mg/kg compared with vehicle-treated control mice, holding promise for the treatment of neurodegenerative and neurological disorders.…”
  16. 216
  17. 217

    Effect of selected feed additives to improve growth and health of dairy calves by Luisa F. L. Salazar (6664121)

    Published 2019
    “…The treatments were: control (CON), monensin (MON; 30 mg/kg of starter), probiotic <i>E</i>. <i>faecium</i> (PROB; 70 mg/kg of starter), essential oils (EO; 300 mg/kg of starter), or PROB + EO (EOPROB). …”
  18. 218
  19. 219

    The primers related to FAM50A. by Longhai Li (4052044)

    Published 2025
    “…Knockdown of FAM50A decreased cell proliferation ability, the proportion of EdU positive cells, and the number of CRC cell colonies, whereas overexpressing FAM50A promoted proliferative phenotypes. …”
  20. 220